跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Blodis-40 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Blodis-40
Approved
STANDARD
Blodis-40
East African (India) Overseas
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
fbb063e0ee00cbd1
Company
East African (India) Overseas
Type
Standard
Approval Details
Approval Id
fbb063e0ee00cbd1
Drug Approval Philippines Name
Blodis-40
Product Name
Blodis-40
Registration Number
DRP-13203
Brand Name
Blodis-40
Generic Name
Methylprednisolone (As Sodium Succinate)
Dosage Form
Lyophilized Powder for Injection (IM/IV)
Dosage Strength
40 mg
Manufacturer
East African (India) Overseas
Importer
Ambica International Corporation.
Distributor
Ambica International Corporation.
Issuance Date
28 December 2022
Expiry Date
28 December 2027
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
fbb063e0ee00cbd1
Type
Standard
Back to Philippines FDA Approvals